Status:
UNKNOWN
Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics
Lead Sponsor:
Alexandria University
Conditions:
Agitation
Eligibility:
All Genders
3-6 years
Phase:
PHASE4
Brief Summary
the investigators hypothesized that Nalbuphine may be alternative pharmacological agent for prevention of emergence agitation in pediatrics who will be scheduled for elective lower abdominal surgical ...
Detailed Description
SEVOFLURANE is widely used popular inhalational anesthetic to induce and maintain anesthesia in children due to its greater hemodynamic stability, less irritation of the airway and low blood gas solub...
Eligibility Criteria
Inclusion
- ASA physical status I \&II
- scheduled for elective lower abdominal surgical procedures (inguinal hernia repair and hypospadias) under general anesthesia
Exclusion
- history of hypersensitivity to the studied drug,
- refusal of the legal guardian
- chronic or acute intake of any sedative or analgesic drugs,
- Psychological\& emotional disorder.
- Cognitive or developmental disorders.
- severely agitated child at induction of anesthesia
- Any neurological condition that would limit the patient's ability to communicate with or understand nursing personnel,
- Existing contraindications to caudal block such as coagulopathy, local and systemic infection.
- Failure of the caudal block.
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 2 2022
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT05273671
Start Date
March 1 2022
End Date
June 2 2022
Last Update
April 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria university
Alexandria, Egypt, 0203